One World Products Inc (PNTT) Gross Profit Margin starting from the third quarter 2022 to third quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
One World Products Inc   (PNTT)


One World Products Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PNTT Gross Profit Margin (Sep 30 2022)
Q3 		(Jun 30 2022)
Q2 		(Mar 31 2022)
Q1 		(Dec 31 2021)
Q4 		(Sep 30 2021)
Q3
Y / Y Revenue Change 325.4 %
Seq. Revenue Change 1.44 %
Revenue In Millions $0.03
Gross Profit Margin 28.18 %
Gross Profit Margin Total Ranking # 2847
Gross Profit In Millions $0.01
Y / Y Gross Profit Change 1094.92 %
Seq. Gross Profit Change -21.63 %


Commenting Third Quarter 2022 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 28.18 % due to increase in Cost of Sales and despite Revenue increase of 1.44 % to $0 millions.
Company's Gross Profit Margin in III. Quarter, was lower than company average.


Observing third quarter 2022 results within Major Pharmaceutical Preparations industry 163 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 2504 to 2847.
Learn about Gross Margin
PNTT's Gross Profit Margin third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 164
Healthcare Sector # 466
Overall # 2795

Gross Profit Margin Statistics
High Average Low
99.59 % 49.75 % 1.88 %
(Jun 30 2021)   (Mar 31 2022)


PNTT Gross Income Trends • More of PNTT's Profitabilty Ratios • PNTT Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
PNTT's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
PNTT's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for PNTT's Competitors
Gross Profit Margin Profit Margin for One World Products Inc 's Suppliers
Gross Profit Margin Profit Margin for PNTT's Customers

You may also want to know
PNTT's Annual Growth Rates PNTT's Profitability Ratios PNTT's Asset Turnover Ratio PNTT's Dividend Growth
PNTT's Roe PNTT's Valuation Ratios PNTT's Financial Strength Ratios PNTT's Gross Profit Growth
PNTT's Roa PNTT's Inventory Turnover Ratio PNTT's Growth Rates PNTT's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2022 MRQ Gross ProfitSep 30 2022 MRQ Revenue
Eli Lilly And Company  77.25 %$ 5,362.500  Millions$ 6,941.600  Millions
Biomarin Pharmaceutical Inc  76.99 %$ 389.056  Millions$ 505.344  Millions
Liquidia Corporation  76.62 %$ 2.425  Millions$ 3.165  Millions
Clovis Oncology inc   76.31 %$ 23.398  Millions$ 30.663  Millions
Reshape Lifesciences Inc  75.09 %$ 2.101  Millions$ 2.798  Millions
Procyon Corporation  74.92 %$ 0.881  Millions$ 1.176  Millions
Rvl Pharmaceuticals Plc  74.81 %$ 7.497  Millions$ 10.022  Millions
Statera Biopharma Inc fka Cytocom Inc   74.74 %$ 0.501  Millions$ 0.670  Millions
Horizon Therapeutics Public Limited Company  74.70 %$ 691.227  Millions$ 925.359  Millions
Abvc Biopharma Inc   74.59 %$ 0.032  Millions$ 0.042  Millions
Zomedica Corp   74.56 %$ 3.561  Millions$ 4.776  Millions
Comera Life Sciences Holdings Inc   74.05 %$ 0.174  Millions$ 0.235  Millions
Merck and Co Inc   73.70 %$ 11,025.000  Millions$ 14,959.000  Millions
Evofem Biosciences Inc   73.63 %$ 4.691  Millions$ 6.371  Millions
Pfizer Inc  73.22 %$ 16,575.000  Millions$ 22,638.000  Millions
Kyntra Bio Inc   72.62 %$ 11.427  Millions$ 15.735  Millions
Novan Inc   71.85 %$ 3.675  Millions$ 5.115  Millions
Bausch Health Companies Inc   71.75 %$ 1,468.000  Millions$ 2,046.000  Millions
Tvardi Therapeutics Inc   71.75 %$ 7.758  Millions$ 10.813  Millions
Nature s Sunshine Products inc   71.65 %$ 74.874  Millions$ 104.506  Millions
Harrow Inc   70.55 %$ 16.102  Millions$ 22.823  Millions
Stablecoin Development Corporation  70.37 %$ 2.375  Millions$ 3.375  Millions
Revance Therapeutics Inc   70.08 %$ 20.334  Millions$ 29.015  Millions
Pacira Biosciences inc   69.74 %$ 116.788  Millions$ 167.466  Millions
Zoetis Inc   69.68 %$ 1,395.000  Millions$ 2,002.000  Millions
Eagle Pharmaceuticals inc   68.33 %$ 45.032  Millions$ 65.901  Millions
Johnson and Johnson  67.19 %$ 15,984.000  Millions$ 23,791.000  Millions
Igc Pharma Inc   66.83 %$ 0.135  Millions$ 0.202  Millions
Abbvie Inc   66.10 %$ 9,790.000  Millions$ 14,812.000  Millions
Kaya Holdings Inc   65.44 %$ 0.113  Millions$ 0.173  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.